A Closer Look: Gilead’s Viread Donation To China
This article was originally published in PharmAsia News
Executive Summary
Gilead’s decision to donate Viread to Chinese HIV patients came at a time when China was updating its compulsory license rules. The U.S. company may have also been thinking about the potential ramifications for hepatitis B, a much larger market in China.